ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells
Håkan Mellstedt(Karolinska University Hospital), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Thomas Olin(Kancera (Sweden)), Amineh Ghaderi(Karolinska University Hospital), Ali Moshfegh(Karolinska University Hospital), Birgitta Sander(Karolinska University Hospital), Ηλίας Δράκος(University of Crete), Anders Österborg(Karolinska University Hospital), Johanna Aschan(Karolinska University Hospital), Fariba Mozaffari(Karolinska University Hospital), Johan Schultz(Kancera (Sweden)), Martin Norin(Kancera (Sweden)), George Z. Rassidakis(Karolinska University Hospital)
Cited by 5
Related Papers
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2010|587
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312